Scientists have clarified how a toxin made by a common gut bacterium attaches to cells in the colon, a step that helps trigger inflammation and tumour growth. The finding answers a long‑standing question in colorectal cancer research and could point towards new ways to block this damage before it begins.
The work, led by researchers at Johns Hopkins University and published in prestigious journal Nature, explains how a toxin from Bacteroides fragilis first gains a foothold on the lining of the bowel.
A bacterium many people carry
Bacteroides fragilis is a normal resident of the human gut and can be found in up to one in five healthy adults. Most strains are harmless. Some, however, produce a protein called B. fragilis toxin, or BFT.
More than 15 years ago, researchers showed that BFT can damage the lining of the colon and promote chronic inflammation. In animal studies, this process was linked to the development of colon tumours, a key step on the path to colorectal cancer.
What remained unclear was how the toxin first attached to colon cells to cause this harm. Today, this mystery has been solved.
What the new research shows
In a series of laboratory and animal experiments, the researchers identified a specific protein on colon cells that the toxin must bind to before it can act. That protein is called claudin‑4.
Claudin‑4 is part of the tight junctions that help seal cells together in the gut lining. When researchers removed claudin‑4 from colon cells grown in the laboratory, the toxin could no longer bind or cause damage.
In simple terms, the study shows that BFT needs claudin‑4 as a docking point. Without it, the toxin cannot reach its true target inside the cell.
How the toxin causes damage
Once attached to claudin‑4, the toxin is able to cut another protein called E‑cadherin. E‑cadherin plays a crucial role in keeping the cells of the colon lining tightly connected.
When E‑cadherin is damaged, the barrier of the gut becomes weaker. This allows inflammation to develop and creates conditions that, over time, can support tumour formation.
The researchers also showed, using purified proteins, that the toxin and claudin‑4 bind directly to each other in a precise one‑to‑one interaction. This confirmed that claudin‑4 is not just associated with the process but is essential to it.
Testing a possible way to block the toxin
The team then explored whether this knowledge could be used to protect the gut. In mouse studies, they created a “decoy” version of claudin‑4, a soluble protein that floats freely rather than sitting on the cell surface.
The toxin bound to the decoy instead of to colon cells, reducing damage to the gut lining. While this approach is still experimental, it suggests that blocking the toxin before it reaches the colon wall may be possible, paving the way to prevent many colorectal cancers in the future.
How strong is the evidence?
The findings are based on a combination of advanced cell experiments, detailed protein studies and animal models. This makes the evidence biologically strong, but it is still preclinical.
The work does not show that B. fragilis causes cancer in people on its own, nor does it suggest that everyone carrying the bacterium is at risk. Colorectal cancer is influenced by many factors, including genetics, diet, lifestyle and the wider gut microbiome.
What this means for the public
For now, this research does not change medical advice or screening recommendations. People should continue to follow existing guidance on bowel cancer screening, which remains the most effective way to detect disease early.
The study helps researchers understand a key biological step that links certain gut bacteria to colon damage.
That knowledge may guide future efforts to prevent or reduce inflammation linked to cancer risk.
Yet to be known
The exact three‑dimensional structure of the toxin bound to claudin‑4 has not yet been captured. Current computer‑based prediction tools were unable to fully resolve this interaction, and further experimental work is needed.
Researchers also need to explore whether similar mechanisms operate in people and how differences in gut bacteria influence risk over time.
A clearer picture of bacteria and cancer risk
This study fills an important gap in understanding how a bacterial toxin interacts with the human gut. By identifying the first point of contact between BFT and colon cells, it provides a clearer view of how long‑term inflammation and tumour development may begin.
Placed alongside growing research into the gut microbiome, the findings highlight how everyday microbes can influence health in subtle but important ways, and why understanding these interactions matters for future disease prevention.
The post Scientists Found How Gut Bacteria Toxins Trigger Colorectal Cancer first appeared on PP Health Malaysia.
